Localization of the insulin-like growth factor system in a rat model of heart failure induced by myocardial infarction

Journal of Histochemistry and Cytochemistry

Volumn 47, Issue 5, 1999, Pages 649-659

  Dean, Rachael ^a   Edmondson, Stephanie R ^b   Burrell, Louise M ^a   Bach, Leon A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Binding protein; Heart failure; In situ hybridization; Insulin like growth factor; Left ventricle; Myocardial infarction; Rat

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TISSUE REPAIR;

ANIMALIA;

EID: 0032911398     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215549904700507     Document Type: Article

References (22)

1. Bach LA, Rechler MM (1995) Insulin-like growth factor binding proteins. Diabetes Rev 3:38-61
2. Brown DL, Kane CD, Chernausek SD, Greenhalgh DG (1997) Differential expression and localization of insulin-like growth factors I and II in cutaneous wounds of diabetic and nondiabetic mice. Am J Pathol 151:715-724
3. Burrell LM, Chan R, Phillips PA, Calafiore P, Tonkin A, Johnston CI (1996) Echocardiographic assessment of cardiac function after myocardial infarction in the rat. Clin Exp Pharmacol Physiol 23:570-572
4. Burrell LM, Phillips PA, Risvanis J, Chan RK, Aldred K, Johnston CI (1998) Long-term effects of non-peptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat. Am J Physiol 275:H176-182
5. Cox KH, DeLeon DV, Angerer LM, Angerer RC (1984) Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 101:485-502
6. Delafontaine P (1995) Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc Res 30:825-834
7. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J, Jr (1995) Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 95:619-627
8. Fazio S, Sabatini D, Capaldo B, Vigorito C, Giordano A, Guida R, Pardo F, Biondi B, Sacca L (1996) A preliminary study of growth hormone in the treatment of dilated cardiomyopathy. N Engl J Med 334:809-814
9. Hodsman G, Kohzuki M, Howes L, Sumithran E, Tsunoda K, Johnston CI (1988) Neurohormonal responses to chronic myocardial infarction in rats. Circulation 78:376-381
10. Kluge A, Zimmerman R, Munkel B, Mohri M, Sack S, Schaper J, Schaper W (1995) Insulin-like growth factor I is involved in inflammation linked angiogenic processes after microembolisation in porcine heart. Cardiovasc Res 29:407-415
11. Kluge A, Zimmerman R, Weihrauch D, Mohri M, Sack S, Schaper J, Schaper W (1997) Coordinate expression of the insulin-like growth factor system after microembolisation in porcine heart. Cardiovasc Res 33:324-331
12. Krishnamurthi RV, Maxwell L, Bassett NS, Gavin JB, Gluckman PD, Johnston BM (1997) The spatial and temporal distribution of insulin-like growth factor-I following experimental myocardial infarction in the rat. Cardiovasc Pathol 6:197-203
13. Le Moine C, Bernard V, Bloch B (1994) Quantitative in situ hybridization using radioactive probes in the study of gene expression in heterocellular systems. In Choo KHA, ed. Methods in Molecular Biology: In Situ Hybridization Protocols. Totowa, NJ, Humana Press, 301-311
14. Li Q, Li B, Wang X, Leri A, Jana K, Liu Y, Kajstura J, Baserga R, Anversa P (1997) Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress and cardiac hypertrophy. J Clin Invest 100:1991-1999
15. Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hanlein D, Willenbrock R, Anker SD, Poole-Wilson PA, Ranke MB, Dietz R (1998) Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. Lancet 351:1233-1236
16. Parrizas M, Saltiel AR, LeRoith D (1997) Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272: 154-161
17. Pfeffer JM, Pfeffer MA, Braunwald E (1987) Haemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocarcial infarction and heart failure. Circulation 75:I149-155
18. Price GJ, Berka JL, Edmondson SR, Werther GA, Bach LA (1995) Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney. Kidney Int 48:402-411
19. Reiss K, Meggs LG, Li P, Olivetti G, Capasso JM, Anversa P (1994) Upregulation of IGF1, IGF1-receptor, and late growth related genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol 158:160-168
20. Sacca L, Cittadini A, Fazio S (1994) Growth hormone and the heart. Endocrin Rev 15:555-573
21. Schaper W, Zimmermann R, Kluge A, Andres J, Sharma HS, Frass O, Knoll R, Winkler B, Verdouw P (1994) Patterns of myocardial gene expression after cycles of brief coronary occlusion and reperfusion. Ann NY Acad Sci 723:284-291
22. Yang R, Bunting S, Gillett N, Clark R, Jin H (1995) Growth hormone improves cardiac performance in experimental heart failure. Circulation 92:262-267